NCT03086148View on ClinicalTrials.gov

Ketamine and Postoperative Depressive Symptom-PASSION

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

July 5, 2017

Primary Completion Date

August 24, 2018

Study Completion Date

November 20, 2018

Conditions
Ketamine; Depressive Symptom; Neurosurgery; Perioperative Period
Interventions
DRUG

Ketamine

Ketamine will be administrated intravenously at dural opening, with the total dose of 0.5 mg/kg and continual infusion for 40 minutes.

DRUG

Normal saline

Normal saline will be administrated intravenously at dural opening, with the total dose of 0.5 ml/kg and continual infusion for 40 minutes.

Trial Locations (1)

100070

Beijing TianTan Hospital, Beijing

All Listed Sponsors
lead

Beijing Tiantan Hospital

OTHER

NCT03086148 - Ketamine and Postoperative Depressive Symptom-PASSION | Biotech Hunter | Biotech Hunter